William Fairey

Chief Operating Officer, ChemoCentryx, Inc.

Companies

Ascendis Pharma A/SBoard member Mar 18, 2026 to now¹
KalVista Pharmaceuticals, Inc.Board member Apr 22, 2024 to now²
Rein Therapeutics, Inc.Board member Nov 2, 2023 to now³
Mirum PharmaceuticalsBoard member Aug 20, 2021 to now⁴
ChemoCentryx, Inc.Chief operating officer Jan 5, 2018 to Jan 5, 2018⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Ascendis Pharma A/S ASND2,117 shares⁶$488.2K at $230.59Mar 18, 2026
Mirum Pharmaceuticals MIRM2,500 shares⁷$205.6K at $82.23Jun 11, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 11, 2025Sold 3,203 shares at $48.42 of Mirum Pharmaceuticals⁷
May 29, 2025Exercised options 5,703 shares of Mirum Pharmaceuticals⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAscendis Pharma A/S, Board member
2
SEC EDGARKalVista Pharmaceuticals, Inc., Board member
3
SEC EDGARRein Therapeutics, Inc., Board member
4
SEC EDGARMirum Pharmaceuticals, Board member
5
SEC EDGARChemoCentryx, Inc., Chief operating officer
6
SEC EDGARAscendis Pharma A/S shares after the filing of Mar 18, 2026
7
SEC EDGARMirum Pharmaceuticals shares after the filing of Jun 11, 2025
8
SEC EDGARForm 4 filed Jun 2, 2025